KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Gross Profit (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -10.62%
Dec 31, 2025 15.22%
Sep 30, 2025 -5.46%
Jun 30, 2025 18.58%
Mar 31, 2025 -12.75%
Dec 31, 2024 4.47%
Sep 30, 2024 -0.12%
Jun 30, 2024 24.88%
Mar 31, 2024 -4.43%
Dec 31, 2023 15.52%
Sep 30, 2023 -22.68%
Jun 30, 2023 16.82%
Mar 31, 2023 -24.76%
Dec 31, 2022 11.86%
Sep 30, 2022 -5.98%
Jun 30, 2022 9.77%
Mar 31, 2022 -10.22%
Dec 31, 2021 6.17%
Sep 30, 2021 5.47%
Jun 30, 2021 7.26%
Mar 31, 2021 -4.11%
Dec 31, 2020 16.84%
Sep 30, 2020 16.95%
Jun 30, 2020 0.55%
Mar 31, 2020 -0.31%
Dec 31, 2019 2.12%
Sep 30, 2019 1.91%
Jun 30, 2019 4.92%
Mar 31, 2019 -2.37%
Dec 31, 2018 -1.84%
Sep 30, 2018 0.90%
Jun 30, 2018 5.61%
Mar 31, 2018 10.06%
Dec 31, 2017 1.47%
Sep 30, 2017 -0.66%
Jun 30, 2017 10.02%
Mar 31, 2017 -6.10%
Dec 31, 2016 6.37%
Sep 30, 2016 -2.36%
Jun 30, 2016 9.98%
Mar 31, 2016 -6.82%
Dec 31, 2015 3.10%
Sep 30, 2015 690.48%
Jun 30, 2015 -119.74%
Mar 31, 2015 -5.42%
Dec 31, 2014 10.39%
Sep 30, 2014 2.94%
Jun 30, 2014 10.11%
Mar 31, 2014 -9.56%
Dec 31, 2013 7.38%
Sep 30, 2013 -1.98%
Jun 30, 2013 14.55%
Mar 31, 2013 -19.41%
Dec 31, 2012 12.79%
Sep 30, 2012 2.16%
Jun 30, 2012 13.36%